Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00133809 · ClinicalTrials.gov registry record · Phase 2
Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression
A Phase 2 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT00133809 is a Phase 2 study that has completed, run by Emory University. The registered enrollment target is 8 participants.
The verdict
NCT00133809, a Phase 2 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
This trial will study the ability of islet transplantation to restore glycemic control and achieve insulin independence in type 1 diabetic subjects with life-threatening hypoglycemia and unawareness, or recurrent hyperglycemia with ketoacidosis.
Interventions
- DRUG Transplantation of Human Islets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2002-07 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00133809
The ClinicalTrials.gov registry entry for NCT00133809 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transplantation of Human Islets is the first listed.
NCT00133809 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00133809 about?
NCT00133809 is a clinical study titled "Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression". This trial will study the ability of islet transplantation to restore glycemic control and achieve insulin independence in type 1 diabetic subjects with life-threatening hypoglycemia and unawareness, or recurrent hyperglycemia with ketoacidosis.
What is the current status of trial NCT00133809?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2002-07. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00133809?
The interventions under investigation include: Transplantation of Human Islets (DRUG).
Who is sponsoring clinical trial NCT00133809?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.